USANA Health Sciences (USNA) Tops Q2 EPS by 16c; Reiterates Guidance

July 27, 2021 4:19 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $1.87, $0.16 better than the analyst estimate of $1.71. Revenue for the quarter came in at $336.8 million versus the consensus estimate of $332.61 million.


Reiterates 2021 net sales and diluted EPS outlook.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities